Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conferences and invited investors to participate by webcast.

  • TD Cowen Health Care Conference, Boston Fireside chat on Monday, March 3, 2025 at 10:30 a.m. ET
  • Raymond James Institutional Investors Conference, Orlando Presentation on Tuesday, March 4, 2025 at 1:05 p.m. ET

The webcasts can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.

About Exact Sciences Corp.

A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.

Derek Leckow Exact Sciences Corp. investorrelations@exactsciences.com 608-893-0009

Grafico Azioni EXACT Sciences (NASDAQ:EXAS)
Storico
Da Gen 2025 a Feb 2025 Clicca qui per i Grafici di EXACT Sciences
Grafico Azioni EXACT Sciences (NASDAQ:EXAS)
Storico
Da Feb 2024 a Feb 2025 Clicca qui per i Grafici di EXACT Sciences